Hollak CE - Search Results

1

Plasma and urinary levels of dermatan sulfate and heparan sulfate derived disaccharides after long-term enzyme replacement therapy (ERT) in MPS I: correlation with the timing of ERT and with total urinary excretion of glycosaminoglycans.

de Ru MH, van der Tol L, van Vlies N, Bigger BW, Hollak CE, Ijlst L, Kulik W, van Lenthe H, Saif MA, Wagemans T, van der Wal WM, Wanders RJ, Wijburg FA. de Ru MH, et al. Among authors: hollak ce. J Inherit Metab Dis. 2013 Mar;36(2):247-55. doi: 10.1007/s10545-012-9538-2. Epub 2012 Sep 19. J Inherit Metab Dis. 2013. PMID: 22991166

2

The effect of enzyme therapy in a patient with Gaucher disease type III.

Bosman DK, Hollak CE, Aerts JM, Bakker HD. Bosman DK, et al. Among authors: hollak ce. J Inherit Metab Dis. 1996;19(5):703-4. doi: 10.1007/BF01799852. J Inherit Metab Dis. 1996. PMID: 8892032 No abstract available.

3

Oligosaccharide excretion in adult Gaucher disease.

de Jong JG, Aerts JM, van Weely S, Hollak CE, van Pelt J, van Woerkom LM, Liebrand-van Sambeek ML, Wevers RA. de Jong JG, et al. Among authors: hollak ce. J Inherit Metab Dis. 1998 Feb;21(1):49-59. doi: 10.1023/a:1005311430722. J Inherit Metab Dis. 1998. PMID: 9501269

4

The natural course of Gaucher disease in The Netherlands: implications for monitoring of disease manifestations.

Maaswinkel-Mooij P, Hollak C, van Eysden-Plaisier M, Prins M, Aerts H, Pöll R. Maaswinkel-Mooij P, et al. J Inherit Metab Dis. 2000 Feb;23(1):77-82. doi: 10.1023/a:1005655031239. J Inherit Metab Dis. 2000. PMID: 10682310

5

Clinically relevant therapeutic endpoints in type I Gaucher disease.

Hollak CE, Maas M, Aerts JM. Hollak CE, et al. J Inherit Metab Dis. 2001;24 Suppl 2:97-105; discussion 87-8. doi: 10.1023/a:1012492429191. J Inherit Metab Dis. 2001. PMID: 11758685 Review.

6

Plasma chitotriosidase and CCL18: early biochemical surrogate markers in type B Niemann-Pick disease.

Brinkman J, Wijburg FA, Hollak CE, Groener JE, Verhoek M, Scheij S, Aten J, Boot RG, Aerts JM. Brinkman J, et al. Among authors: hollak ce. J Inherit Metab Dis. 2005;28(1):13-20. doi: 10.1007/s10545-005-4416-9. J Inherit Metab Dis. 2005. PMID: 15702402

7

Manifestations of Fabry disease in placental tissue.

Vedder AC, Strijland A, vd Bergh Weerman MA, Florquin S, Aerts JM, Hollak CE. Vedder AC, et al. Among authors: hollak ce. J Inherit Metab Dis. 2006 Feb;29(1):106-11. doi: 10.1007/s10545-006-0196-0. J Inherit Metab Dis. 2006. PMID: 16601876

8

CCL18: a urinary marker of Gaucher cell burden in Gaucher patients.

Boot RG, Verhoek M, Langeveld M, Renkema GH, Hollak CE, Weening JJ, Donker-Koopman WE, Groener JE, Aerts JM. Boot RG, et al. Among authors: hollak ce. J Inherit Metab Dis. 2006 Aug;29(4):564-71. doi: 10.1007/s10545-006-0318-8. Epub 2006 May 30. J Inherit Metab Dis. 2006. PMID: 16736095

9

Substrate reduction therapy of glycosphingolipid storage disorders.

Aerts JM, Hollak CE, Boot RG, Groener JE, Maas M. Aerts JM, et al. Among authors: hollak ce. J Inherit Metab Dis. 2006 Apr-Jun;29(2-3):449-56. doi: 10.1007/s10545-006-0272-5. J Inherit Metab Dis. 2006. PMID: 16763917

10

Restricted upper extremity range of motion in mucopolysaccharidosis type I: no response to one year of enzyme replacement therapy.

Cox-Brinkman J, Smeulders MJ, Hollak CE, Wijburg FA. Cox-Brinkman J, et al. Among authors: hollak ce. J Inherit Metab Dis. 2007 Feb;30(1):47-50. doi: 10.1007/s10545-006-0490-x. Epub 2006 Dec 11. J Inherit Metab Dis. 2007. PMID: 17160613

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

315 results

Search Page